Chunlian Liang

424 total citations
11 papers, 334 citations indexed

About

Chunlian Liang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chunlian Liang has authored 11 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Chunlian Liang's work include Metabolism, Diabetes, and Cancer (2 papers), Pancreatic function and diabetes (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Chunlian Liang is often cited by papers focused on Metabolism, Diabetes, and Cancer (2 papers), Pancreatic function and diabetes (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Chunlian Liang collaborates with scholars based in China and United States. Chunlian Liang's co-authors include Chuan Qin, Hua Zhu, Weilin Yang, Yingna Li, Chunmei Ma, Lan Huang, Ying Liu, Wei Deng, Yanfeng Xu and Lin Zhang and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Chunlian Liang

11 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunlian Liang China 10 160 125 70 41 38 11 334
Venkatesan Raghavan United States 6 261 1.6× 146 1.2× 93 1.3× 19 0.5× 27 0.7× 6 453
Gui Zhang China 11 240 1.5× 138 1.1× 63 0.9× 52 1.3× 30 0.8× 26 509
Fenfang Zhan China 8 156 1.0× 57 0.5× 100 1.4× 54 1.3× 26 0.7× 14 312
Teng Wan China 11 206 1.3× 125 1.0× 55 0.8× 41 1.0× 24 0.6× 34 413
Laura C. Hinte Switzerland 8 211 1.3× 72 0.6× 92 1.3× 17 0.4× 31 0.8× 9 360
Ta‐Tsung Lin Taiwan 12 399 2.5× 106 0.8× 72 1.0× 36 0.9× 67 1.8× 22 590
Christine Couch United States 9 184 1.1× 54 0.4× 38 0.5× 11 0.3× 32 0.8× 10 381
Lunxu Li China 15 122 0.8× 45 0.4× 32 0.5× 45 1.1× 39 1.0× 17 514
Kalpana Shrivastava Spain 13 111 0.7× 55 0.4× 61 0.9× 42 1.0× 12 0.3× 13 482
Mengna Peng China 9 256 1.6× 53 0.4× 36 0.5× 42 1.0× 53 1.4× 16 511

Countries citing papers authored by Chunlian Liang

Since Specialization
Citations

This map shows the geographic impact of Chunlian Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlian Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlian Liang more than expected).

Fields of papers citing papers by Chunlian Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlian Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlian Liang. The network helps show where Chunlian Liang may publish in the future.

Co-authorship network of co-authors of Chunlian Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlian Liang. A scholar is included among the top collaborators of Chunlian Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlian Liang. Chunlian Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liang, Chunlian, et al.. (2023). DAB2 promotes pulmonary fibrosis and may act as an intermediate between IGF‑1R and PI3K/AKT signaling pathways. Experimental and Therapeutic Medicine. 25(4). 183–183. 3 indexed citations
2.
4.
Zong, Yuanyuan, Pin Yü, Hongxia Cheng, et al.. (2015). miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer׳s disease. Brain Research. 1624. 95–102. 40 indexed citations
5.
Liang, Chunlian, et al.. (2015). The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis. Experimental and Molecular Pathology. 99(2). 279–285. 33 indexed citations
6.
Li, Xiuli, Jin Li, Xiaolan Lu, et al.. (2015). Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. International Journal of Molecular Medicine. 36(3). 767–775. 15 indexed citations
7.
Liang, Chunlian, et al.. (2015). Melatonin inhibits tunicamycin-induced endoplasmic reticulum stress and insulin resistance in skeletal muscle cells. Biochemical and Biophysical Research Communications. 463(4). 1102–1107. 38 indexed citations
8.
Zhang, Lin, et al.. (2014). TCF2 Attenuates FFA-Induced Damage in Islet β-Cells by Regulating Production of Insulin and ROS. International Journal of Molecular Sciences. 15(8). 13317–13332. 15 indexed citations
9.
Zhang, Lin, Yingna Li, Chunlian Liang, & Weilin Yang. (2013). CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. International Journal of Molecular Medicine. 33(2). 478–486. 35 indexed citations
10.
Zhang, Jie, Chadi G. Abdallah, Junqing Wang, et al.. (2012). Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients. Psychiatry Research. 200(2-3). 126–132. 18 indexed citations
11.
Liang, Chunlian, Hua Zhu, Yanfeng Xu, et al.. (2011). MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Research. 1455. 103–113. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026